Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J, Christian Barrett"'
Autor:
Scott Satko, Bassam Omar, Elaine A. Muchmore, John D. Buckley, Diana B. McNeill, Vera P. Luther, Patricia Cornett, Thomas Bradley, Sheilah Bernard, Ellen Cohen, Teresa Roth, Alec B. O'Connor, Ethan D. Fried, Nancy D. Adams, J. Christian Barrett, Jiselle Petrusky, John F. McConville, Nancy Palapiano, Richard Alweis, Michael Frank, Lisa Arfons, S. Elkins, Richard I. Kopelman
Publikováno v:
Barrett, JC; Alweis, R; Frank, M; O'Connor, A; Mcconville, JF; Adams, ND; et al.(2015). Adoption of a Uniform Start Date for Internal Medicine Fellowships and Other Advanced Training: An AAIM White Paper. American Journal of Medicine, 128(9), 1039-1043. doi: 10.1016/j.amjmed.2015.05.024. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5v53p5jn
The American journal of medicine, vol 128, iss 9
The American journal of medicine, vol 128, iss 9
Author(s): Barrett, J Christian; Alweis, Richard; Frank, Michael; O'Connor, Alec; McConville, John F; Adams, Nancy Day; Arfons, Lisa; Bernard, Sheilah; Bradley, Thomas; Buckley, John D; Cohen, Ellen; Cornett, Patricia; Elkins, Stephanie; Kopelman, Ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5752ec8a4a022f23bf136926f0018d85
http://www.escholarship.org/uc/item/5v53p5jn
http://www.escholarship.org/uc/item/5v53p5jn
Autor:
Erika J. Martin, Janice Kuhn, Mirella Ezban, Donald F. Brophy, Ulla Hedner, J Christian Barrett, Melinda E Nolte
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 22(6)
In a previous pharmacokinetic/pharmacodynamic study in nonbleeding hemophilia patients, variability in laboratory response to recombinant factor VIIa (rFVIIa) 90 μg/kg was noted, and the patients were described as delayed or rapid laboratory respond
Autor:
D F, Brophy, E J, Martin, J, Christian Barrett, M E, Nolte, J G, Kuhn, P M, Gerk, M E, Carr, H, Pelzer, H, Agersø, M, Ezban, U, Hedner
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(5)
Recombinant FVIIa is a haemostatic agent administered to patients with severe FVIII or FIX deficiency with inhibitors. Although rFVIIa is effective at stopping bleeding, a reliable assay to monitor its effect is lacking. To characterize the pharmacok
Autor:
Henrik Agersø, Mirella Ezban, Hermann Pelzer, Donald F. Brophy, M. E. Nolte, Janice Kuhn, Erika J. Martin, Marcus E. Carr, P M Gerk, Ulla Hedner, J Christian Barrett
Publikováno v:
Haemophilia.
Summary. Recombinant FVIIa is a haemostatic agent administered to patients with severe FVIII or FIX deficiency with inhibitors. Although rFVIIa is effective at stopping bleeding, a reliable assay to monitor its effect is lacking. To characterize the
Autor:
Janice Kuhn, Melinda E Nolte, Erika J. Martin, J Christian Barrett, Donald F. Brophy, Mirella Ezban
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 21(6)
To evaluate the hemostatic effects of NN1731 and rFVIIa, an ex-vivo study in hemophilia patients used the Hemodyne Hemostasis Analysis System (HAS) to measure platelet contractile force (PCF), clot elastic modulus (CEM), and force onset time (FOT), a
Autor:
J Christian, Barrett
Publikováno v:
Herpes : the journal of the IHMF. 7(1)
Post-transplant lymphoproliferative disorders are a varied group of disease processes that follow both solid organ and bone marrow transplantation. The disorders are typically associated with the Epstein-Barr virus and, as a consequence, have contrib
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.